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ABSTRACT
Objectives To develop a behavioural intervention 
package to support clinicians and patients to amend 
incorrect penicillin allergy records in general practice. 
The intervention aimed to: (1) support clinicians to refer 
patients for penicillin allergy testing (PAT), (2) support 
patients to attend for PAT and (3) support clinicians 
and patients to prescribe or consume penicillin, when 
indicated, following a negative PAT result.
Methods Theory- based, evidence- based and person- 
based approaches were used in the intervention 
development. We used evidence from a rapid review, 
two qualitative studies, and expert consultations with the 
clinical research team to identify the intervention ‘guiding 
principles’ and develop an intervention plan. Barriers 
and facilitators to the target behaviours were mapped to 
behaviour change theory in order to describe the proposed 
mechanisms of change. In the final stage, think- aloud 
interviews were conducted to optimise intervention 
materials.
Results The collated evidence showed that the key 
barriers to referral of patients by clinicians were limited 
experience of referral and limited knowledge of referral 
criteria and PAT. Barriers for patients attending PAT 
were lack of knowledge of the benefits of testing and 
lack of motivation to get tested. The key barriers to the 
prescription and consumption of first- line penicillin 
following a negative test result were patient and clinician 
beliefs about the accuracy of PAT and whether taking 
penicillin was safe. Intervention materials were designed 
and developed to address these barriers.
Conclusions We present a novel behavioural intervention 
package designed to address the multiple barriers to 
uptake of PAT in general practice by clinicians and 
patients. The intervention development details how 
behaviour change techniques have been incorporated to 
hypothesise how the intervention is likely to work to help 
amend incorrect penicillin allergy records. The intervention 
will go on to be tested in a feasibility trial and randomised 
controlled trial in England.
BACKGROUND
Incorrect penicillin allergy records are 
common, as side effects and symptoms of 
illness can be mistaken for allergic reaction 
symptoms.1 About 6% of the UK general 
practice population has a record of a peni-
cillin allergy but fewer than 10% of these 
patients are likely to be truly allergic.2 Peni-
cillin allergy refers to an allergy to a whole 
group of antibiotics (penicillins), which 
are first- line antibiotics for many common 
infections. As a result of incorrect penicillin 
allergy labels, a significant portion of the 
population is denied effective antibiotics. 
Moreover, penicillin allergy records are also 
linked to antimicrobial resistance: evidence 
suggests that patients with a penicillin allergy 
label are more likely to be prescribed broad 
Strengths and limitations of this study
 ► Intervention development was conducted using a 
systematic and iterative process
 ► Evidence- based, theory- based and person- based 
approaches were used which consisted of three it-
erative stages: collating the evidence on views and 
experiences of penicillin allergy testing, intervention 
planning informed by theory and optimisation of in-
tervention materials
 ► These approaches were used to increase the feasi-
bility and acceptability of the intervention to its tar-
get users (general practitioners and patients)
 ► This approach clearly maps how the intervention 
components are hypothesised to change clinician 
and patient target behaviours
 ► The views of other general practice prescribers 
(such as nurse prescribers and pharmacists) should 
be considered in future research
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spectrum antibiotics and to acquire antibiotic resistance 
infections.3 4
Penicillin allergy testing (PAT) is already provided in 
the National Health Service (NHS) in specialist clinics5 
and offers the opportunity to confirm or discount a peni-
cillin allergy label. This service is only available to a subset 
of patients following National Institute for Health and 
Care Research (NICE) guidance.6 Current assessment is 
performed over two clinic visits.
The Allergy Antibiotics and Microbial resistance 
(AlABAMA) Study aims to develop a behavioural inter-
vention package for UK general practice to effectively 
amend incorrect penicillin allergy records. The interven-
tion package is designed to target both general practice 
clinicians and patients with a suspected incorrect peni-
cillin allergy record. It introduces a pre- emptive ‘peni-
cillin allergy assessment pathway’ (PAAP) that targets 
patients assessed as ‘low risk’ of true allergy, who are not 
at risk of anaphylaxis or other severe adverse reactions, 
and it aims to streamline the test process by undertaking 
patient history screening in general practice (stage 1) 
and introducing an efficient one- stop procedure at a 
hospital clinic for the PAT. The test includes either a skin 
test (ST), testing penicillin solution on the forearm (stage 
2) and oral challenge test (OCT), taking doses of peni-
cillin solution over time (stage 3), or just OCT depending 
on the individual patient. Following the PAT, patients and 
practices would receive confirmation of a patient’s allergy 
status. The AlABAMA intervention will be trialled in a 
national randomised controlled trial in winter 2020–2021. 
It will test how corrections of incorrect penicillin allergy 
records and subsequent penicillin prescribing influence 
recovery and patients taking antibiotics for infections.
This paper describes the planning, development 
and optimisation of the AlABAMA PAAP intervention 
package.
METHODS AND RESULTS
Intervention planning methodology
We followed an integrated approach to intervention 
development that combines theory- based, evidence- 
based and person- based approaches.7–9 This approach 
has been successfully used in the development of a variety 
of behavioural interventions including for reduction of 
antibiotic prescriptions in European general practice.10
Patient and public involvement (PPI)
The AlABAMA programme grant involved PPI members, 
as co- applicants, and study advisors from the start so 
research questions were informed by their input. The 
results of all work from the AlABAMA programme will 
be disseminated with the help from our PPI co- applicants 
and our existing PPI networks towards the end of the 
programme grant.
The AlABAMA intervention package was developed 
in three stages described below. The methods and key 
results for each stage are presented below.
Stage 1: collating and analysing evidence
Rapid review methods
The full rapid review is available elsewhere.11 Rapid 
review is a form of synthesis that supports the review 
of existing evidence in a timely manner.12 It aimed to 
explore clinicians’ and patients’ views and experiences 
of PAT services.
Results
The review identified only two studies that reported 
patients’ views of PAT. The first study sought patients’ 
views on undertaking a three- step testing procedure 
consisting of prick testing, intradermal testing and oral 
challenge.13 It found that patients thought that PAT 
provided a valuable medical information; however, this 
was measured using a single- item questionnaire (‘Do you 
think undergoing testing for penicillin allergy provides 
important information for your penicillin history?’). The 
second study recruited patients who attended general 
allergy clinic and were given a brief five- question survey 
examining their views of PAT.14 This study found that 
patients were not aware of PAT and had limited under-
standing of penicillin allergy, but also expressed their 
interest in being tested.
The review also identified six studies on clinicians’ 
views of PAT13 15–19 three of which specifically focused 
on barriers and facilitators to using PAT.13 17 19 One of 
the studies included both patient and clinician views.19 
Clinicians reported several barriers to referring patients 
for PAT. These included difficulties establishing the 
allergy history, lack of knowledge on referral processes 
and organisational pressures making allergy testing a 
low priority.13 17 19 A number of clinicians and patients 
reported being reluctant to prescribe or consume peni-
cillin after a negative PAT result.
Qualitative methods
Full details of the qualitative work are available else-
where.20 Two qualitative studies were undertaken by MW; 
one interviewing 19 general practitioners (GPs) and the 
second interviewing 31 patients with a penicillin allergy 
record (16 with previous experience of PAT). The aim 
was to identify clinicians’ and patients’ views on the 
barriers and facilitators for PAT and antibiotic use after a 
negative test. Semistructured interviews were conducted 
over the phone by an experienced qualitative researcher 
(PhD qualified) with substantial previous experience of 
conducting qualitative research. Clinicians were identi-
fied in general practices and by the local microbiology 
services. Patients were identified from a general adult 
hospital allergy clinic and from general practices in the 
same geographical area. Interview topic guides were 
informed by the existing literature, which indicated 
potential barriers and facilitators to target behaviours.20 
Written informed consent was obtained from all partici-
pants. An inductive thematic analysis approach was used 
to analyse data.21
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Results
Clinicians reported that they often felt that penicillin 
allergy records were incorrect, however, reported uncer-
tainty about how to identify patients with true penicillin 
allergy and were reluctant to amend medical records 
without objective evidence. Penicillin allergy status was 
not seen to be a major problem in general practice due 
to the availability of alternative antibiotics and clini-
cians struggled to identify the risks of incorrect allergy 
records. Clinicians were seen to differ in their consul-
tation styles when speaking to patients about their anti-
biotic prescribing decisions and allergy status. They 
reported lack of experience of PAT services and the need 
for more information on referral criteria. Regarding the 
process of changing a patients’ record after a negative test 
result, clinicians reported being happy to update medical 
records on directions from secondary care but were 
unsure who was responsible for making sure that patients 
understood allergy test results.
The majority of patients who were motivated to get 
tested had experienced a negative consequence of having 
a penicillin allergy label (such as limited availability of 
antibiotics they could use). Patients reported concerns 
about the possibility of having an allergic reaction during 
PAT; the degree of the severity of their previous reac-
tions affected how apprehensive they were about the test. 
Moreover, when the test was perceived as more invasive, 
for example, the OCT compared with the ST, patients 
reported being more concerned about PAT. Patients were 
also concerned about how much they would be moni-
tored during the test and highlighted the importance 
of being informed, kept safe and observed by qualified 
professionals. Some patients reported being unsure 
about a negative test result and feeling anxious about 
taking penicillin if prescribed, as they doubted whether 
the test result was accurate.
Expert discussions
In addition to our core team (which included three 
psychologists), the wider clinical research team included 
a consultant immunologist, a consultant microbiolo-
gist, a consultant anaesthetist, a GP and professors with 
expertise in applied health research. As part of this first 
stage, we consulted our wider clinical research team using 
monthly teleconferences and emails to gain their feed-
back on several aspects of the intervention development.
Results
The expert discussions informed the interpretation of 
the evidence collated in the rapid review and the quali-
tative studies, the development of early iterations of the 
intervention materials and the development of the initial 
intervention plan and components.
Stage 2: intervention planning and development
Creating guiding principles
In line with the person- based approach,7 brief guiding 
principles were created to be consulted through the 
whole intervention development process. This ensured 
that the intervention met the original objectives. As a 
first step to creating guiding principles, characteristics 
and behavioural needs of the target users were identi-
fied based on the findings of the rapid review, qualita-
tive interviews and expert discussions. The second step 
involved identification of intervention objectives and key 
design features, which would address these needs.
Results
Table 1 presents the AlABAMA guiding principles. These 
focused on increasing confidence to refer and attend for 
PAT and increasing motivation to prescribe/consume 
penicillin following a negative PAT result. Guiding prin-
ciples also included increasing clinician confidence in 
discussing penicillin allergy with patients and improving 
communication between primary and secondary care 
about penicillin allergy status. Lastly, the intervention 
needed to present the PAAP as reliable and trusted and 
provide accessible and easy to use materials for clinicians 
and patients.
Behavioural analysis
The aim of the behavioural analysis was to use behaviour 
change theory to describe the content of the AlABAMA 
intervention package and map the evidence from the 
rapid review, qualitative studies and expert consultations. 
We used a model of behaviour known as capability, oppor-
tunity, motivation, behaviour (COM- B).22 According to 
this model, behaviour is a result of these three constructs. 
Changing behaviour requires overcoming any presenting 
barriers in each of these areas. The behaviour change 
wheel (BCW)23 offers a systematic way to develop interven-
tions to change each of these constructs. A more specific 
description of elements which can be delivered within 
intervention components is provided in a taxonomy of 
93 behaviour change techniques (behaviour change tech-
nique taxonomy, v1; BCTTv1).24
Methods
The first step of the behavioural analysis process was to 
define the problem in behavioural terms, which resulted 
in the identification of the four specific target behaviours.
As a second step, we identified what needed to change 
using the Theoretical Domain Framework (TDF),25 
which includes 14 domains such as knowledge, skills 
and beliefs about capabilities. Each domain of the TDF 
relates to a COM- B component. This step allowed us 
to identify target behaviours, their barriers and facilita-
tors, and how intervention components would support 
desired behaviour change based on evidence collated in 
stage 1.
Finally, the intervention components were mapped 
to the TDF framework and the BCW referring to the 
BCTv1.24 This produced a list of TDF barriers to the 
target behaviours, target constructs (what needs to 
change for the behaviour to occur), intervention func-
tions (ways an intervention can change behaviour) 
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and behaviour change techniques used for each of the 
barriers/facilitators.
Results
The full behavioural analysis is presented in online 
supplemental materials S1. First, we identified barriers 
and facilitators to referral of low- risk patients to PAT and 
patient attendance to PAT. The analysis highlighted that 
both clinicians’ and patients’ knowledge and percep-
tions of penicillin allergy and test procedures could be 
modified; information needed to be supported by scien-
tific evidence for clinicians and patients to be reassured 
that the test was safe. We designed a resource for clini-
cians entitled ‘Penicillin Allergy Testing: Information 
for general practice’, which contained information on 
penicillin allergy and PAAP procedures. As part of the 
AlABAMA Trial, this will be supported by site training and 
working instructions, which provide practical guidance 
on screening patients and referral to PAT (relevant BCTs 
for clinicians were ‘information about antecedents’ and 
‘information about health consequences’).
For patients we developed two patient booklets, one to 
be provided prior to PAT and one following a negative 
test result. All patients, on entering the trial, will have a 
consultation with a GP to answer questions and address 
concerns about PAT. We developed a patient booklet 
entitled ‘Penicillin Allergy Testing: going for a test’, 
which included information on PAAP procedures and 
PAT safety (relevant BCTs for patients were ‘information 
about health consequences’ and ‘feedback on outcomes 
of the behaviour’).
The barriers to the prescription and consumption of 
first- line penicillin following a negative test result were 
patient and clinician beliefs about the accuracy of PAT and 
whether taking penicillin was safe. Clinicians also needed 
reassurance that colleagues saw delabelling as beneficial 
and resources to support them in changing incorrect 
penicillin allergy records. We developed a second patient 
booklet entitled ‘Penicillin Allergy Testing: a negative test 
result’, which contained information about which anti-
biotics patients could safely take in the future following 
a negative test result, a negative result intervention card 
and a result letter which confirmed the patient allergy 
status to penicillin (relevant BCTs were ‘social support’ 
and ‘restructuring of the social and physical environ-
ment’). As part of the trial, clinicians will receive working 
instructions, which contain guidance on how to change 
the patient allergy label in medical records, result letter 
which confirms the patient allergy status to penicillin and 
an electronic pop- up, which includes a reminder of the 
patient’s new allergy status (relevant BCTs were ‘feedback 
on outcomes of behaviour’ and ‘adding objects to the 
environment’).
Logic modelling
The next step included the development of a logic model, 
which summarised the behavioural analysis, providing 
a diagrammatic representation of the hypothesised 
Table 1 Guiding principles for the AlABAMA intervention package
Intervention design objectives Key features
To present the PAAP as a reliable and trusted 
approach to confirm allergy status
 ► Present the PAAP as a trusted/scientific/official way to get a confirmed PAT 
result, for both clinicians and patients
To increase clinician’s confidence in referring 
patients, and patients’ motivation to attend, for PAT
 ► Provide evidence on the potential harms of an incorrect penicillin allergy 
records and the process of testing in the information pack
 ► Provide opportunity to address patients’ concerns about potential benefits 
and risks of testing by both clinicians and allergists during consultations 
before the allergy test and during the appointment at the immunology clinic
To motivate clinicians/patients to prescribe/take 
penicillin following a negative PAT test result
 ► Provide information to clinicians about the clinical meaning of a test result 
and its implication as part of the information pack
 ► Provide information to patients about the PAT (process) and the potential 
benefits of being able to take penicillin in the pretest intervention booklet
To increase clinicians’ ability to discuss PAT with 
patients
 ► Provide training for general practice clinicians about penicillin allergy and 
PAT, including its accuracy, implications, benefits
To improve communication between primary and 
secondary care so that allergy status records are 
correct
 ► Provide a clear and consistent approach to delabelling with support from 
colleagues in secondary care and preventing relabelling in the future
 ► Provide information about who is responsible for ensuring patients 
understand the results and for updating the medical records during the site 
training and in the information pack
 ► Provide clear and precise documentation of side effects during future 
courses of penicillin in the information pack
To provide easily accessible tools that are suitable 
for use by general practice clinicians
 ► Make interventions materials for clinicians accessible, short, easy to follow, 
easy to implement and not increase workload
To provide easily accessible resources for patients  ► Make patients materials brief, easy to read, accessible
 ► Make materials easy to carry with them at all time and that provide evidence 
of the results of their test
PAAP, penicillin allergy assessment pathway; PAT, penicillin allergy testing.
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processes and causal pathways from the intervention 
components to the desired outcomes.26 27
Methods
The research team opted for a process oriented iterative 
logic model, which was refined during the whole inter-
vention development stage.
Results
The logic model (figure 1) included four components:
Intervention components and techniques
Intervention components were organised based on the 
two target groups (clinicians and patients). Intervention 
techniques summarised the BCTs used as part of the 
intervention, which were identified in the behavioural 
analysis.
Intervention processes
These were the psychological factors that explained the 
relationships between the intervention components 
and the outcome of the intervention. These processes 
were described in terms of TDF domains. Each interven-
tion technique was hypothesised to mainly affect one of 
these processes. As part of the intervention, clinicians 
would receive information on penicillin allergy and 
implications of incorrect allergy records in order to 
increase their knowledge of PAT and allergies. In addi-
tion to this, providing medical and scientific evidence 
and current guidelines on how to perform PAT would 
change their professional identity related to their role 
in the referral process and act as reinforcement to 
increase their motivation to refer patients in the future. 
Regarding the processes affecting patient’s attendance 
of PAT, providing evidence of penicillin as best treat-
ment and the safety of PAT would increase their beliefs 
of positive consequences of accurate records; informing 
them of common reactions during PAT and reassuring 
them of monitoring at the clinic and at home would 
increase their knowledge on PAT, decrease their nega-
tive emotions, such as anxiety, and act as positive rein-
forcement to attend the clinic.
Both patients and clinicians would receive evidence of 
the accuracy of PAT, and of safety of prescribing penicillin 
after a negative test result, in order to increase their belief 
about positive consequences of prescribing penicillin 
after a negative test result. Finally, providing a negative 
test result card to use with clinicians would affect patients’ 
expectations of social influences regarding clinician’s 
acceptance of the test result.
Purported mediators
These are the target behaviours of the intervention, 
which directly affect the outcomes. In the logic model, 
the assessment of potential incorrect penicillin records 
was operationalised as the referral of low- risk patients to 
PAT and patient attendance at PAT. The introduction 
of the PAAP was hypothesised to affect the change of 
incorrect penicillin allergy records (clinician changing 
medical records and patient acceptance of change of 
penicillin allergy status), which would ultimately affect 
the consumption of penicillin.
Outcomes
The behavioural outcomes of the model were the 
prescription and consumption of first- line penicillin 
when indicated.
Stage 3: optimising the intervention materials
The development of the intervention materials was part 
of an iterative process that was initially informed by the 
findings of the rapid review, qualitative interviews and 
expert consultations. Once the first drafts of the interven-
tion materials were developed, a think- aloud approach 
was used with clinicians and members of the PPI group 
for the aim of feedback on intervention materials. As 
this did not constitute a formal qualitative evaluation, 
ethical approval was not required. This series of think- 
aloud consultations with clinicians and PPI representa-
tives was conducted in order to gain their insights on the 
content, usability and format of the clinician ‘Penicillin 
Allergy Testing: Information for general practice’ leaflet 
and two patient booklets (‘Penicillin Allergy Testing: 
going for a test’ and ‘Penicillin Allergy Testing: a nega-
tive test result’). Subsequently to the feedback received 
by the participants in the think- aloud consultations and 
discussions in further expert consultations, the inter-
vention materials were optimised. Verbal consent was 
obtained from all participants, who agreed to take part in 
the consultations and for notes to be taken. Consultations 
were not recorded and interviews were only used to refine 
intervention materials.
Think-aloud consultations with GPs
Methods
Think- aloud telephone consultations were conducted 
with six participants by MW; two additional participants 
provided feedback via email. Four of the participants 
had previously taken part in the qualitative study on GP 
views on the barriers and facilitators for PAT and antibi-
otic use after a negative test (mentioned in the section 
Figure 1 AlABAMA logic model. PAAP, penicillin allergy 
assessment pathway; PIS, participant inforamation sheet; 
TDF, Theoretical Domain Framework; WI, Working Instruction.
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Qualitative methods); four additional participants were 
recruited using convenience sampling. Consultations 
were not recorded, but the interviewer took detailed 
notes. Consultations focused on GP views of each section 
of the ‘Penicillin Allergy Testing: Information for general 
practice’ (online supplemental materials S2).
Results
The leaflet was well received. Participants reported that 
it was informative, useful and generally easy to read. 
The participants perceived it not only as information for 
themselves, but also a tool to use in a consultation with 
patients. Some participants felt that they knew about the 
consequences of incorrect penicillin allergy record; and 
therefore, the leaflet could be shortened. Most partici-
pants understood the testing stages; however, a couple of 
participants were confused about which stages of the test 
patients could skip. One participant wanted exact doses of 
penicillin specific (rather than just amounts). Regarding 
the section on patient discussions, some clinicians felt 
that there was no need to discuss the test with patients. 
Participants queried whether being tested with amoxi-
cillin meant that the patient could now take all penicillin- 
based antibiotics and wanted more information.
Clinicians’ feedback was collated and organised in a 
‘table of changes’ (online supplemental materials S3) 
where suggested changes were listed and given a level 
of priority for that change, following the Must Should 
Could Would (MoScoW) framework,28 and the source 
of the suggested change (expert opinion, research team, 
clinical research team, literature review). Changes to the 
‘Penicillin Allergy Testing: Information for general prac-
tice’ leaflet included changes to the title, to the exact 
doses of penicillin given to the patients during the test, 
information about side effects and information about 
which antibiotics patients with a negative test result can 
take safely.
Think-aloud consultations with patients
Methods
Think- aloud consultations were conducted with seven 
patients (three with experience of PAT and four with no 
experience) by MW. Five of these patients had previously 
taken part in the qualitative study on views on the barriers 
and facilitators for PAT and antibiotic use after a nega-
tive test (mentioned in the section Qualitative methods). 
These participants were asked at the end of the initial 
interview whether they would like to comment on the 
intervention materials at a later date; the additional two 
participants were identified using convenience sampling. 
Again, consultations were not recorded, but the inter-
viewer took detailed notes. Consultations asked their 
views about the two patient booklets (‘Penicillin Allergy 
Testing: going for a test’ and ‘Penicillin Allergy Testing: 
a negative test result’) and the intervention card (online 
supplemental materials S2).
Results
The booklets and intervention card were very well 
received by the participants. Participants considered the 
booklets to have the right amount of information and 
felt they were generally easy to read. Patients reported 
that the booklets convinced them that going for a PAT 
could be beneficial. They felt that they could relate to the 
description of how people were given penicillin allergy 
labels. Patients thought the description of the test was 
clear and they knew what to expect. Statistics about the 
prevalence of allergy were not always understood by the 
participants, as the participants often thought that 1 in 10 
people are allergic and they wanted a more visual presen-
tation of this key information. Participants were unsure 
what narrow and broad spectrum antibiotics were and did 
not recognise Methicillin- resistant Staphylococcus aureus 
(MRSA) abbreviation. Participants did not always know 
that penicillin is more than one antibiotic. The partici-
pants wanted to have a separate paragraph on what could 
happen during the test and what could happen during 
3 days of taking penicillin at home. They also wanted reas-
surance that 3 days would be enough to detect delayed 
reactions. The participants wanted more reassurance that 
after being tested with one type of penicillin (eg, amoxi-
cillin), it would mean that they could safely take all peni-
cillin antibiotics. The participants were slightly concerned 
about the risk of allergic reaction in the future (despite 
negative test results).
Patient feedback was collated in a table of changes. 
Changes made to the booklets were the selection of new 
images of patients for the front cover, inclusion of defini-
tions of narrow and broad spectrum antibiotics, and reas-
surance that 3 days of oral challenge would be enough to 
detect delayed reactions to penicillin.
Intervention components
The development and optimisation of clinician and 
patient intervention materials was part of an iterative 
process. Figures 2 and 3 present the example of this 
Figure 2 Example of intervention development for clinician 
materials. BCT, behaviour change technique; BCW, behaviour 
change wheel; PAT, penicillin allergy testing; TDF, Theoretical 
Domain Framework.
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process for the development of one section of the ‘Peni-
cillin Allergy Testing: going for a test’ patient booklet 
and the ‘Information for General Practice’ leaflet for 
clinicians.
All Working Instructions (WI) developed to support 
clinicians and research nurses activities as part of the 
AlABAMA intervention package were shown to a group 
of clinicians to gain their feedback on content and layout. 
Among the clinicians who provided feedback there were 
two practice managers, and one nurse. Their overall feed-
back was positive and the main changes to the interven-
tion materials included the identification of the best way 
of updating the patient’s medical records after PAT, and 
the introduction of screenshots of the medical record in 
the working instructions.
All participants’ letters (patient appointment letter, 
patient result letter, clinician result letter) were developed 
among the wider clinical and research team in order to 
make them effective in motivating patient to attend the 
PAT and in order to persuade clinician to change patient 
records and prescribe penicillin after a negative test 
result, and patient to consume penicillin after a negative 
test result.
At the end of the intervention development stage, a 
description of the intervention was completed following 
the Templete for intervention description and replica-
tion (TIDieR)29 guidance (online supplemental mate-
rials S4) together with a description of the intervention 
components for clinicians and patients (table 2). We have 
followed the Guidance for reporting intervention devel-
opment studies in health research (GUIDED)30 check-
list (online supplemental materials S5), when reporting 
intervention development in this paper.
DISCUSSION
This paper describes the development of the AlABAMA 
intervention package, which aimed to change behaviours 
that facilitate PAT and subsequently amend incorrect 
allergy records in English general practice. Such changes 
in clinician and patient behaviours have potential 
to significantly impact on antibiotic prescribing and 
consumption. The approach used here has previously 
been used for the development of behaviour change 
interventions targeted to reduce antibiotic prescribing 
by clinicians in primary31 and secondary care,32 but it is 
the first time that this approach has been used to develop 
an intervention to amend incorrect penicillin allergy 
records. The transparency of the intervention develop-
ment process will inform intervention developers on how 
this methodology could be used in different contexts, and 
will facilitate the comparison with other interventions 
which have used similar processes.
The evidence collated from the rapid review and quali-
tative interviews allowed in- depth understanding of partic-
ipant needs (lack of knowledge of PAT, lack of knowledge 
of negative consequences of allergy labels) and which 
behavioural influences needed to be modified as part 
of the intervention. The mapping of these behavioural 
influences and the AlABAMA intervention package 
components to behaviour change theory and the logic 
model allowed a transparent reporting of the psycholog-
ical processes that are hypothesised to explain the effect 
of the intervention components on the outcomes. More 
specifically it highlighted the BCTs used in each compo-
nent of the AlABAMA intervention package and how they 
addressed the barriers identified in the rapid review and 
qualitative work. It also explained which psychological 
mechanisms were hypothesised to change by the inter-
vention components (clinicians’ knowledge on penicillin 
allergy and PAT procedures, patients’ beliefs about posi-
tive consequences of taking the PAT) and which target 
behaviours (referral and attendance to PAT, prescription 
and consumption of penicillin first line) would likely 
affect the intervention outcomes. Think- aloud interviews 
with patients and clinicians, and in- depth feedback from 
the clinical research team on the intervention materials, 
highlighted changes that needed to be made in order to 
increase their acceptability and potential effectiveness.
The AlABAMA intervention package targeted clini-
cian referral of patients for PAT and updating incorrect 
penicillin allergy records; factors previously identified in 
previous qualitative research as barriers to effective peni-
cillin allergy delabelling.11–20 Recent exploration of clini-
cian reported barriers and enablers to identifying and 
delabelling hospital inpatients with incorrect penicillin 
allergy records has highlighted the need to introduce 
patient education concerning the risks of avoiding peni-
cillin.24 Inconsistencies in the management of penicillin 
allergic patients were reported, together with a lack of 
time to discuss allergy testing, and the need to improve 
communication between primary and secondary care 
about patient allergy status, as well as updating of patient 
medical records.33 A previous exploration of views about 
implementing delabelling of patients ahead of elec-
tive surgery identified barriers to implementing it on a 
large scale, such as human factors linked to anxiety and 
financial implications. These human factors were: lack of 
interest from patients in undertaking an allergy test; lack 
Figure 3 Example of intervention development for patient 
materials. BCT, behaviour change technique; BCW, behaviour 
change wheel; PAT, penicillin allergy testing; TDF, Theoretical 
Domain Framework.
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of acceptance of the test result among clinicians; high 
proportion of patient relabelled themselves after a nega-
tive testing for penicillin allergy or relabelling by health-
care professionals. The financial barrier was significant 
despite long- term cost benefit, as there is an upfront cost 
to perform the test.34
A limitation of the AlABAMA intervention package is to 
how widely applicable it might be. Allergy services across 
the UK vary significantly, and access to specialist testing 
ranges widely. The AlABAMA programme will focus on 
one geographical area (the North of England), which 
will be covered by the specialist allergy unit participating 
in the AlABAMA Trial. The intervention will be centred 
around functionality to be incorporated into SystemOne 
(an electronic medical record system widely used in 
general practice) but the intervention package is not 
necessarily suitable for use in other areas of England, the 
UK or wider. The contextual factors to delivery should be 
considered. Moreover, it is only a small group of patients 
(around 25%–30%) who are suitable to undergo the 
abbreviated test (patient history, ST and OCT). Many will 
still require full assessment by an immunologist or aller-
gist as per current guidelines. Cost- effectiveness analysis 
of the PAT and intervention package as a whole will be 
carried out the in upcoming AlABAMA Trial.
CONCLUSIONS
Current clinical practice involves referral to PAT with 
little attention to other elements of the pathway that help 
to ensure that testing impacts positively on patient care. 
This study presents the development of a behavioural 
intervention package to support the process of amending 
incorrect penicillin allergy records. Numerous barriers to 
the uptake of PAT have been identified as well as penicillin 
prescribing and consumption following a negative test. 
Table 2 Overview of the key intervention components of the AlABAMA intervention package
Intervention components Description
For clinicians
“Penicillin Allergy Testing: Information for 
general practice” leaflet
Information leaflet that includes evidence- based information to increase knowledge 
about PAT and motivation to refer patients to PAT and prescribe penicillin after a 
negative PAT result
Electronic health record pop- up Electronic pop- up on medical records. which tells clinicians that patient has had a 
negative test result and that their allergy status needs to be amended
Allergy result letter A letter is sent to the GP to inform them of the patient’s penicillin allergy test result, 
including details on which test(s) they undertook, whether it is safe or not to prescribe 
penicillin in the future and instructions on how to change the allergy label
Consultation with patients Discussions with patients to check eligibility for the trial and to answer any queries 
about the trial and PAAP testing
Site training and working instructions Training in trial procedures delivered to GP leads including provision of information on 
penicillin allergy delabelling, the referral process, the three stages of the PAAP and the 
interpretation of test results
For patients in intervention arm
‘Penicillin Allergy Testing: going for a test’ 
booklet
A booklet to inform patients, in the PAAP intervention arm, about incorrect allergy 
records, how they may benefit from having a penicillin allergy test and what the test 
involves
Penicillin allergy test appointment letter The letter includes information on the PAAP procedures in hospital, including pretest 
assessment and monitoring during the test and at home
Penicillin allergy assessment pathway (PAAP) Appointment at the immunology clinic for patients in the PAAP intervention arm. At 
the appointment, patients will complete stage 1, stage 2 and/or stage 3 of the PAAP 
pathway
Allergy test result letter Patient will receive a letter with information on the result of their allergy test and 
whether it is safe or not to take penicillin in the future
‘Penicillin Allergy Testing: a negative test 
result’ booklet
A booklet on the reliability of the test results and consequences of a negative test result 
(sent with allergy test result letter).
Post- test intervention card Laminated credit card- sized card that says which test the patient has had and confirms 
the negative allergy result
For all patients in control and intervention arm
An invitation letter and participant information 
sheet
An invitation letter and participant information sheet on the purpose of the trial and 
what the research study would involve for patient participants
Discussion with clinicians Discussion with clinicians about attending the test to ask any queries around the 
benefits of taking the test and why removing the incorrect record might be good
GP, general practitioner; PAT, penicillin allergy testing.
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We have identified relevant behaviour change techniques 
to inform the development of the AlABAMA intervention 
package to overcome these barriers. The intervention is 
currently being tested in a feasibility trial in primary care 
to lead on to a randomised controlled trial.
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